Call for Abstract

6th International Conference on Epilepsy & Treatment, will be organized around the theme “Progressive study and emerging therapies for improvement of Epileptic life”

Epilepsy 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Epilepsy 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Epilepsy is a chronic noncommunicable and Neurological disorder of the brain that affects people of all ages. Epilepsy occurs when brain activity becomes abnormal, causing seizures. Seizures can affect any process your brain coordinates. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

  • Track 1-1Generalized seizures
  • Track 1-2Absence seizures
  • Track 1-3Tonic-clonic seizures
  • Track 1-4Focal seizures

Epilepsy is a chronic disorder with diverse clinical characteristics that preclude a singular mechanism a neurological disorder marked by sudden recurrent episodes of seizures. A seizure occurs when part of the brain receives a burst of abnormal electrical signals that temporarily interrupts normal electrical brain function. It is one of the most common disorders of the nervous system and affects people of all ages, races, and ethnic background. The fact that multiple mechanisms exist is not surprising given the varied ways the normal nervous system controls this balance. In contrast, understanding seizures in brain of an individual with epilepsy is more difficult because seizures are typically superimposed on an altered nervous system.

  • Track 2-1Birth trauma
  • Track 2-2Alcohol or drugs
  • Track 2-3Brain tumor
  • Track 2-4Neurological problems
  • Track 2-5Stroke
  • Track 2-6Alzheimers disease

Epileptogenesis is the chronic process by which a normal brain develops epilepsy. Epilepsy is a chronic condition in which seizures occur. These changes to the brain occasionally cause neurons to fire in a hyper-synchronous manner, known as a seizure. Epileptogenesis can be triggered by genetic or acquired factors, and that can continue long after epilepsy diagnosis.

  • Track 3-1Traumatic brain injury (TBI)
  • Track 3-2Stroke
  • Track 3-3Cerebral Tumor
  • Track 3-4Intracranial hemorrhage
  • Track 3-5Status epilepticus
  • Track 3-6Seizures
  • Track 3-7Epilepsy

Epilepsy can begin at any time of life, but it is most commonly diagnosed in children and people over the age of 65. More than half of children with epilepsy will outgrow their seizures as they mature, while others may have seizures that continue into adulthood. Although epilepsy varies from person to person, children with epilepsy generally have seizures that respond well to medication. Epilepsy affects around 1 in every 200 children and young people under 18 Children having idiopathic. About two-thirds of all children with epilepsy outgrow their seizures by the time they are teenagers. However, it is important for parents to help their child maintain a healthy lifestyle and ensure regular medical visits.

  • Track 4-1Febrile convulsions
  • Track 4-2Childhood absence epilepsy
  • Track 4-3Epilepsy in gender & age
  • Track 4-4Seizures in childhood
  • Track 4-5Attention Deficit Hyperactivity Disorder (ADHD)

Women with epilepsy have a number of unique concerns during pregnancy. Pregnant women with epilepsy constitute 0.5% of all pregnancies. Some antiepileptic drugs considered safe to the foetus may be associated with increased risk of seizures and maternal mortality. Factors such as epilepsy, anticonvulsant-induced teratogenicity, patient's genetic predisposition and the severity of convulsive disorder may attribute to adverse pregnancy outcome for the children of women with epilepsy.

  • Track 5-1Epilepsy during pregnancy
  • Track 5-2Anti-epileptic drugs
  • Track 5-3Pregnancy and Motherhood
  • Track 5-4Brain infections

Medications can control seizures in most people with epilepsy, but they don’t work for everyone. About 30% of people taking the drugs can’t tolerate the side effects. A person's type of seizures and where they begin in the brain are key to deciding what kind of surgery may help. Surgery has three main goals, they are Remove the area of the brain that causes seizures, Disrupt the nerve pathways that seizure impulses take through your brain, Implant a device to treat epilepsy. An operation on the brain can control seizures and improve your quality of life.

  • Track 6-1Focal Resection
  • Track 6-2Lobectomy
  • Track 6-3Multiple Subpial Transection
  • Track 6-4Hemispherectomy / Hemispherotomy
  • Track 6-5Corpus callosotomy
  • Track 6-6Stereotactic Radiosurgery
  • Track 6-7Neurostimulation Device Implantations

Seizure medicines do not control seizures or can cause bothersome side effects in at least 3 out of 10 people with epilepsy. Seizure alert devices are useful in letting family members know if a seizure is occurring, especially parents of young children. The devices can notify nearby family or caregivers when a seizure occurs through alarms, phone calls or text alerts, depending on the device. They may also be able to give rescue medications or call for an ambulance if the seizure lasts too long or the person has repeated seizures.

  • Track 7-1Vagus Nerve Stimulation
  • Track 7-2Seizure Alarms
  • Track 7-3Medic Alert bracelet
  • Track 7-4Anti-suffocation pillows
  • Track 7-5Mattress devices
  • Track 7-6Cameras
  • Track 7-7Smart watches

Doctors have developed when an individual experience a seizure for the first time doctors advices him for EEG and observes for abnormality in the of  EEG these tests differentiate patient from epileptic to non- epileptic .Research suggests that patients are only suggested to medicated for epilepsy only after their  occurrence of second seizure. Many non-epileptic patients experience an unusual brain activity so; it is advised to record EEG while sleeping is preferable. Brain scans like CT- SCAN are used.

  • Track 8-1EEG
  • Track 8-2CT SCAN
  • Track 8-3Magnetic Resonance Imaging (MRI)
  • Track 8-4Positron Emission Tomography (PET)
  • Track 8-5Single Photon Emission Tomography
  • Track 8-6Magneto Encephalogram
  • Track 8-7MRS
  • Track 8-8Medical history
  • Track 8-9Blood tests

Epilepsy is a common condition of the brain in which a person has a tendency to have recurrent unprovoked seizures. About 1 out of 10 people may have a seizure during his or her lifetime. Safety precautions should be sensible and relevant to the person, with a balance between risk and restrictions. That means seizures are common, and one day you might need to help someone during or after a seizure. First aid for seizures is aimed at keeping the person safe until the seizure stops on its own.

  • Track 9-1Epileptic seizure first aid
  • Track 9-2Sudden unexpected death in epilepsy (SUDEP)
  • Track 9-3Seizure emergencies
  • Track 9-4Epilepsy and General Hazards
  • Track 9-5Epilepsy and Safety

Sudden Unexpected Death in Epilepsy (SUDEP) is a fatal complication of epilepsy. SUDEP accounts for 7–17% of deaths among people with epilepsy. This is the leading cause of death in people with uncontrolled seizures. Patients with uncontrolled seizures are at greatest risk for SUDEP, and experiencing tonic-clonic seizures, taking multiple antiepileptic drugs and having coexisting neurologic disease further increase the risk.

 

  • Track 10-1Uncontrolled or Frequent Seizures
  • Track 10-2Generalized convulsive Seizures
  • Track 10-3Epilepsy in Childhood
  • Track 10-4Missed doses of Medicine
  • Track 10-5Alcohol or Drugs

The interest in Cannabis-based products for the treatment of refractory epilepsy has skyrocketed in recent years. Treatment-resistant epilepsy (TRE) affects 30% of epilepsy patients and is associated with severe morbidity and increased mortality. Cannabis-based therapies have been used to treat epilepsy for millennia, but only in the last few years have we begun to collect data from adequately powered Placebo-controlled, Randomized trials (RCTs) with Cannabidiol (CBD), a cannabis derivative.

Emotional distress is common in people with epilepsy (PWE) for which efficacious interventions are required. Developing evidence-based treatments should be based on testable models of the psychological mechanisms maintaining Psychopathology. The Self-Regulatory Executive Function (S-REF) model proposes that maladaptive Metacognitive beliefs and processes are central to the development and maintenance of emotional distress. Although preliminary support exists for the role of metacognitive beliefs in emotional distress in PWE, their role has yet to be tested when controlling for the contribution made by illness perceptions.

  • Track 12-1Anxiety
  • Track 12-2Depression

Cognitive disorders are common in patients with epilepsy. Their aetiology is multifactorial, being affected by the type and location of the epileptogenic lesion, Epileptic syndrome, type of seizures, and age of onset, frequency and severity. Timely diagnosis and treatment can help to reduce their impact on the patient's quality of life.

  • Track 13-1Temporary Confusion
  • Track 13-2A Staring Spell
  • Track 13-3Uncontrollable Jerking Movements of the Arms and Legs
  • Track 13-4Loss of Consciousness or Awareness

Preventing seizures and other problems must be part of seizure management. This means working together with your health care team to control seizures as best as possible. Maintaining Ketogenic diet, regular exercise can reduce the risk of Epilepsy, get plenty of sleep during nights and avoid using drugs and alcohol, taking seizure medicines regularly as problems taking medicines is one of the biggest risks for uncontrolled seizures. Epilepsy due to medication can be subsided by discontinuing the medicines, controlling stress, anxiety & other emotional issues can reduce the risk of Epilepsy. People can also adjust their lifestyle and environment to reduce the chance of seizures.

  • Track 14-1Anticonvulsants
  • Track 14-2Anti-Epileptogenic Drugs
  • Track 14-3Anti-Seizure Medications
  • Track 14-4Vagus Nerve Stimulation
  • Track 14-5Ketogenic Diet

The Ketogenic Diet (KD) is a modality of treatment used since the 1920s as a treatment for intractable epilepsy. The Ketogenic diet is a special high-fat, low-carbohydrate diet that helps to control seizures in some people with epilepsy. It is usually used in children with seizures that do not respond to medications. Evidence shows that KD and its variants are a good alternative for non-surgical pharmacoresistant patients with epilepsy of any age.

  • Track 15-1Classic Ketogenic Diet
  • Track 15-2Medium Chain Triglyceride (MCT) Diet
  • Track 15-3Ketone Bodies: Anticonvulsant Effects
  • Track 15-4Low Glycaemic Index Treatment (LGIT)

Epilepsy treatment has been applied to treat patients with intractable epilepsy for decades that are not controlled by neither antiepileptic drugs (AEDs) nor surgical candidates. If Antiepileptic drugs aren't controlling your seizures and brain surgery isn't suitable for you, there are other procedures that could help to control Epileptic Seizures.

  • Track 16-1Laser Ablation
  • Track 16-2SEEG
  • Track 16-3Neuromodulation therapy
  • Track 16-4Vagal Nerve or Deep Brain Stimulation

Before modern seizure medicines were developed, people with epilepsy and their doctors looked for a remedy in various herbs and combinations of herbs. Good news is, there are some natural remedies for seizures. Before advanced seizure medications were even discovered, doctors used herbs to treat this condition. Herbs for seizures are still used today because of their impressive effectiveness.

  • Track 17-1Burning Bush
  • Track 17-2Lily of the Valley
  • Track 17-3Hydrocotyle
  • Track 17-4Groundsel
  • Track 17-5Mugwort

Epilepsy can be treated in a number of ways. One of the most preferred forms of treatment is Homeopathy. Homeopathy addresses both the physical symptoms of the disease and the underlying factors triggering it. Another big advantage of homeopathic treatment is that it has negligible side effects.

  • Track 18-1Cicuta
  • Track 18-2Artemisia Vulgaris
  • Track 18-3Cuprum Met
  • Track 18-4Bufo Rana
  • Track 18-5Hyoscyamus

The role of Immunity and Inflammation appears to be an integral part of the pathogenic processes associated with some seizures, particularly with refractory epilepsy. Prompt treatment with Immunotherapy may lead to better outcomes. Immune treatment options for treatment of epilepsy include therapies such as corticosteroids, Immunoglobulin’s, Plasmapheresis, or steroid-sparing drugs such as azathioprine.

  • Track 19-1Intravenous Immunoglobulin Therapy
  • Track 19-2Corticosteroids
  • Track 19-3Immunoglobulins
  • Track 19-4Plasmapheresis
  • Track 19-5Azathioprine

Zonisamide Ethosuximide is now available as rectal gel so that can be applied by family members for prolonged seizures. Drug combination sometimes lead to adverse effects like fatigue and loss of appetite so, combinations are often replaced by Monotherapy, unless monotherapy achieves desired results. When medication doesn’t achieve the required targets doctor can sometimes suggest for surgery 64% cases showed seizure free cases who undergone surgery.

  • Track 20-1Valproic acid
  • Track 20-2Carbamazepine
  • Track 20-3Lamotrigine
  • Track 20-4Levetiracetam

The global market for Antiepileptic drugs is driven by advancement in drugs modification. Over the past several periods, the number of available Antiepileptic drugs has more than doubled. Many of the presently available Antiepileptic drugs have basics pharmacokinetics and more small effects on liver metabolism that converts into a lower rate of side effects, The antiepileptic drug market is threatened by generic competition, which has risen dramatically in the face of patent expirations among various major branded Antiepileptic drugs. These are the major restraints for the Global antiepileptic drugs market.

  • Track 21-1Carbamazepine
  • Track 21-2Phenobarbital
  • Track 21-3Phenytoin
  • Track 21-4Primidone
  • Track 21-5Topiramate

The epilepsies have many possible causes, but for up to half of people with epilepsy a cause is not known. In other cases, the epilepsies are clearly linked to genetic factors, developmental brain abnormalities, infection, traumatic brain injury, stroke, brain tumors, or other identifiable problems.

  • Track 22-1Epilepsy and Parkinson Disease
  • Track 22-2Epilepsy and Alzheimers Disease
  • Track 22-3Epilepsy and Dementia
  • Track 22-4Epilepsy and Stroke
  • Track 22-5Epilepsy and Autism
  • Track 22-6Epilepsy and Brain Tumor
  • Track 22-7Epilepsy and Schizophrenia

Epilepsy is not a mental illness. In fact, the vast majority of people living with epilepsy have no cognitive or psychological problem. For the most part, psychological issues in epilepsy are limited to people with severe and uncontrolled epilepsy.

  • Track 23-1Epilepsy and Intellectual Disability
  • Track 23-2Epilepsy and Depression
  • Track 23-3Epilepsy and Cognitive Disorders
  • Track 23-4Epilepsy and Anxiety
  • Track 23-5Epilepsy and Behavioural Issues

According to WHO, It is estimated that every year nearly 2.4 million people are diagnosed with Epilepsy and there are 4 to 5 in a group of 1000 people with active Epilepsy. Nearly 80% of the individuals with Epilepsy is found in developing regions, Epilepsy represents 0.6%, of the worldwide weight of sickness.